 |
EVIDENCE-BASED SCREENING AND PREVENTION STRATEGIES
From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy
Saturday, October 12, 2013
8:30 a.m.–4:30 p.m.
|
ACCP 2013 Annual Meeting * October 13-16, 2013 * Albuquerque, New Mexico
About From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy
From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy is one component of the professional development program developed by ACCP and approved by the Board of Pharmacy Specialties (BPS) for the recertification of the Board Certified Ambulatory Care Pharmacist (BCACP).
This live education series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It provides participants with active learning exercises designed to advance their skills and abilities to critically evaluate scientific evidence and clinical trials and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.
More information on the BCACP recertification professional development program is available at www.accp.com/careers/boardbcacp.aspx.
Activity Overview
“Evidence-Based Screening and Prevention Strategies” will provide an overview of contemporary evidence-based screening and prevention strategies for cardiovascular diseases, type 2 diabetes mellitus, and chronic kidney disease in the ambulatory care setting.
Target Audience
Clinical pharmacists and BCACPs seeking recertification credit by continuing education
Continuing Pharmacy Education Credit
 |
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This is an application-based activity; Activity Number: 0217-0000-13-109-L01-P. |
To earn continuing pharmacy education credit and to receive your continuing pharmacy education statement of credit for this activity, participants must attend all 6.0 contact hours of programming and complete the associated evaluation at www.accp.com/ce. Partial credit is not available for this activity.
BCACP Recertification Credit
To be eligible for 6.0 CPE hours of recertification credit, BCACPs must attend all 6.0 contact hours of live programming and successfully complete a Web-based posttest by November 30, 2013. Partial credit is not available for this activity.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Summarize important mechanisms and risk factors for the development of cardiovascular diseases, type 2 diabetes mellitus, and chronic kidney disease.
- Develop a comprehensive plan for screening patients with cardiovascular diseases, type 2 diabetes mellitus, and chronic kidney disease in the ambulatory care setting.
- Given a case, assess a patient’s risk for the development or progression of the above diseases.
- Formulate evidence-based recommendations for the primary and secondary prevention of each of the above diseases and complications.
Agenda
| 8:30 a.m. |
Introduction |
| 8:45 a.m. |
Cardiovascular Diseases |
| 10:15 a.m. |
Break |
| 10:30 a.m. |
Type 2 Diabetes Mellitus |
| Noon |
Lunch |
| 1:30 p.m. |
Chronic Kidney Disease |
| 3:00 p.m. |
Break |
| 3:15 p.m. |
Patient Cases and Panel Discussion |
| 4:15 p.m. |
Closing Remarks |
Learning objectives for each of the sessions are available at www.accp.com/meetings/am13/.
Program Faculty
 |
Amy Barton Pai, Pharm.D., BCPS, FASN, FCCP
Associate Professor of Pharmacy Practice
Albany College of Pharmacy and Health Sciences
Adjunct Associate Professor of Internal Medicine, Division of Nephrology and Hypertension,
Albany Medical College
Albany, New York
|
 |
Karen J. McConnell, Pharm.D., FCCP, BCPS (AQ Cardiology)
Clinical Pharmacy Specialist in Cardiology
Kaiser Permanente Colorado
Denver, Colorado
|
 |
Julie M. Sease, Pharm.D., BCPS, CDE, BCACP
Professor & Interim Assistant Dean for Academic Affairs
Presbyterian College School of Pharmacy
Clinton, South Carolina
|
Program Reviewers
Oralia V. Bazaldua, Pharm.D., FCCP, BCPS
Associate Professor
The University of Texas Health Science Center at San Antonio
Department of Family & Community Medicine
San Antonio, Texas
Katie E. Cardone, Pharm.D., BCACP, FNKF
Assistant Professor, Dept. of Pharmacy Practice
Albany Nephrology Pharmacy Group (ANephRx)
Albany College of Pharmacy and Health Sciences
Albany, New York
M. Shawn McFarland, Pharm.D., BCPS, BCACP, BC-ADM
Associate Service Chief of Pharmacy, Clinical & Educational Programs
Clinical Pharmacy Specialist Primary Care
Residency Program Director-PGY-2 Ambulatory Care Residency
VA Tennessee Valley Healthcare System, Alvin C. York Campus
Associate Professor
University of Tennessee College of Pharmacy
Murfreesboro, Tennessee
Registration Fee
| |
Early (September 6) |
Late (September 27) |
On-site |
| ACCP Member |
$200 |
$255 |
$295 |
| Nonmember |
$315 |
$370 |
$410 |
Registration fee includes program booklet, CPE credit, and access to the BCACP recertification posttest.
Full information on the agenda, learning objectives, faculty, and registration is available at www.accp.com/meetings/am13/.
No commercial support has been received for this activity.